Retinal Vasculopathy with Cerebral Leukoencephalopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-04-23
Clinical Trial Update: Crizanlizumab for Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL) [Phase 2]
Phase 2 trial of crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy (RVCL) has completed and results are posted.